$LFMD Balance Sheet | Understand Stock

$LFMD

$2.12 +$0.04 (1.92%) Close

$LFMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of May 8, 2024	Q1 FY2024 As of Mar 11, 2024	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current Assets
Cash
Accounts receivable
Product deposit
Inventory, net
Other current assets
Current assets of discontinued operations
Total Current Assets
Non-current Assets
Equipment, net
Right of use assets, net
Capitalized software, net
Goodwill
Intangible assets, net
Non-current assets of discontinued operations
Total Non-current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable and accrued expenses
Accounts payable
Accrued expenses
Notes payable, net
Current operating lease liabilities
Current portion of convertible long-term debt
Deferred revenue
Current liabilities of discontinued operations
Total Current Liabilities

Long-term Liabilities
Long-term debt, net
Lease liability
Contingent consideration on purchase of WorkSimpli
Convertible long-term debt, net
Noncurrent operating lease liabilities
Contingent consideration
Purchase price payable
Non-current liabilities of discontinued operations

Total Liabilities
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of June 30, 2025 and December 31, 2024
Series B Preferred Stock
Total preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of June 30, 2025 and December 31, 2024
Stockholders’ Equity
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $35.8 million as of June 30, 2026 and December 31, 2025
Common Stock, $0.01 par value; 100,000,000 shares authorized, 47,923,532 and 46,760,016 shares issued, 47,820,492 and 46,656,976 outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, 103,040, at cost, as of June 30, 2026 and December 31, 2025
Total Stockholders’ Equity
Non-controlling interest of discontinued operations
Total Stockholders’ Equity (Deficit)
Total Liabilities and Stockholders’ Equity

Comments